<DOC>
	<DOCNO>NCT01011686</DOCNO>
	<brief_summary>Fecal incontinence affect 18.4 % adult community greatly impact quality life . There 's problem like inconvenience , pain allergic response many therapeutic method surgical operation material injection . ANT-SM autologous adipose-derived stem cell , , expect immune response . In study , patient give injection ANT-AM anal sphincter follow 4 week test safety .</brief_summary>
	<brief_title>Safety Study Autologous Cultured Adipose -Derived Stem Cells Fecal Incontinence</brief_title>
	<detailed_description />
	<mesh_term>Fecal Incontinence</mesh_term>
	<criteria>Older 18 year Wexner 's fecal incontinence score &gt; egal 5 patient fecal incontinence 6 month Continuity anal sphincter endorectal ultrasound abnormality anal function anorectal manometry negative urine betaHCG woman childbearing age agreement participate , sign informedconsent Anorectal surgery within last 6 month prior study patient allergy bovinederived material anesthetic patient diagnosis auto immune disease Diagnosis HBV , HCV , HIV infectious disease Patients diagnosis active Tuberculosis Patient pregnant breastfeeding Women within 6 month post partum Patient unwilling use `` effective '' method contraception study Patients diagnosis Inflammatory Bowel Disease Patient clinically relevant history abuse alcohol drug Insufficient adipose tissue manufacture ANTSM Patient investigator consider suitable study Patients history surgery malignant cancer past 5 year Patient undergo anorectal surgery Patient history artificial anal sphincter surgery Patient take cytotoxic drug within last 30 day Patient investigator consider suitable study reason severe anorectal disease , severe constipation , fistula , rectal prolapse neurological disease ( spinal cord injury , multiple sclerosis , Parkinson 's disease )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>